These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9050032)

  • 1. Chemotherapy and immunomodulation in the elderly.
    Fraschini F; Gattei G; Maierna GG
    Nephrol Dial Transplant; 1996; 11 Suppl 9():31-3. PubMed ID: 9050032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin as immunomodulator in immunodeficient mice.
    Caroleo MC; Frasca D; Nisticó G; Doria G
    Immunopharmacology; 1992; 23(2):81-9. PubMed ID: 1534792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin: immune modulation of spleen cells in young, middle-aged and senescent mice.
    Atre D; Blumenthal EJ
    Mech Ageing Dev; 1998 Jul; 103(3):255-68. PubMed ID: 9723902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin: buffering the immune system.
    Carrillo-Vico A; Lardone PJ; Alvarez-Sánchez N; Rodríguez-Rodríguez A; Guerrero JM
    Int J Mol Sci; 2013 Apr; 14(4):8638-83. PubMed ID: 23609496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin as a new possible anti-inflammatory agent.
    Lissoni P; Rovelli F; Meregalli S; Fumagalli L; Musco F; Brivio F; Brivio O; Esposti G
    J Biol Regul Homeost Agents; 1997; 11(4):157-9. PubMed ID: 9582617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of biological response modifiers on effector cells with cytotoxic activity against tumors.
    Herberman RB
    Semin Oncol; 1986 Jun; 13(2):195-9. PubMed ID: 2424088
    [No Abstract]   [Full Text] [Related]  

  • 7. Interferons in malignancy: biological products or biological response modifiers?
    Krown SE
    J Natl Cancer Inst; 1988 May; 80(5):306-9. PubMed ID: 2451752
    [No Abstract]   [Full Text] [Related]  

  • 8. [Melatonin lowers the threshold of light sensitivity of the human retina].
    Arushanian EB; Ovanesov KB
    Eksp Klin Farmakol; 1999; 62(2):58-60. PubMed ID: 10340133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biological immunomodulators in the treatment of cancer].
    Bello C; Richard C; Hermosa V; Iriondo A; Muruzábal MJ; Pérez Encinas M; Zubizarreta A
    Sangre (Barc); 1988 Apr; 33(2):132-43. PubMed ID: 2456623
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of pidotimod on the function of the human immune system: in vitro and ex vivo study].
    Borghi MO; Minonzio F; Fain C; Carbonelli V; Barcellini W; Del Papa N; La Rosa L; Piona A; Gambini D; Meroni PL
    Drugs Exp Clin Res; 1993; 19 Suppl():37-43. PubMed ID: 8625781
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of bushen huayu composite on secretion of lymphocytic interleukin-2 and interleukin-2 receptor expression in the aged].
    Wang RR; Liu SB
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2002 Jan; 22(1):25-7. PubMed ID: 12585166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of interleukin-2 on rosette formation and its dependence on the serotonin level].
    Eliseeva LS
    Biull Eksp Biol Med; 1993 Aug; 116(8):183-6. PubMed ID: 8274697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects and mechanisms of melatonin on immune responses in mice of different months.
    Wei W; Shen YX; Dai M; Chen Q
    Acta Pharmacol Sin; 2003 Jul; 24(7):719-23. PubMed ID: 12852842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interferons in cascade of cytokines: historic and modern aspects].
    Kuznetsov VP
    Antibiot Khimioter; 1998; 43(5):28-40. PubMed ID: 9644521
    [No Abstract]   [Full Text] [Related]  

  • 15. Immune selection, senescence and adjuvant.
    Tang H
    Sci China Life Sci; 2013 May; 56(5):391. PubMed ID: 23633069
    [No Abstract]   [Full Text] [Related]  

  • 16. Melatonin and cancer.
    Zamfir Chiru AA; Popescu CR; Gheorghe DC
    J Med Life; 2014 Sep; 7(3):373-4. PubMed ID: 25408757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of melatonin on the glucocorticoid-induced immunity suppression studied in vitro].
    Eksp Klin Farmakol; 2005; 68(1):45-7. PubMed ID: 15786965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The medical significance of interferons and their inducers].
    Ershov FI
    Vestn Ross Akad Med Nauk; 2004; (2):9-13. PubMed ID: 15101201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversibility of age associated NK defect by endocrinological and/or nutritional intervention.
    Provinciali M; Pieri C; Fabris N
    Ann Ist Super Sanita; 1991; 27(1):61-6. PubMed ID: 1720296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Augmentation of lymphokine-activated killer (LAK) cell activity by combination of low dose interleukin 2 and several kinds of biological response modifiers (BRMs)].
    Ohnishi H; Okuno K; Nakamura T; Nakamura Y; Yasutomi M
    Nihon Gan Chiryo Gakkai Shi; 1988 Oct; 23(10):2539-45. PubMed ID: 3264846
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.